Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Iron, Hepcidin, and Death in Human AKI.

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, Eisenga MF, Singh K, Babitt JL, Kellum JA, Palevsky PM, Christov M, Waikar SS.

J Am Soc Nephrol. 2019 Feb 8. pii: ASN.2018100979. doi: 10.1681/ASN.2018100979. [Epub ahead of print]

PMID:
30737269
2.

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA.

Am J Kidney Dis. 2018 Dec 19. pii: S0272-6386(18)31087-4. doi: 10.1053/j.ajkd.2018.10.006. [Epub ahead of print]

PMID:
30578152
3.

Implantable cardioverter defibrillators in chronic kidney disease.

Mc Causland FR, Pfeffer MA.

Nat Rev Nephrol. 2018 Jun;14(6):357-358. doi: 10.1038/s41581-018-0007-5. No abstract available.

PMID:
29651098
4.

Association of Albuminuria With Major Adverse Outcomes in Adults With Congenital Heart Disease: Results From the Boston Adult Congenital Heart Biobank.

Rajpal S, Alshawabkeh L, Almaddah N, Joyce CM, Shafer K, Gurvitz M, Waikar SS, Mc Causland FR, Landzberg MJ, Opotowsky AR.

JAMA Cardiol. 2018 Apr 1;3(4):308-316. doi: 10.1001/jamacardio.2018.0125.

PMID:
29541749
5.

Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.

Leaf DE, Siew ED, Eisenga MF, Singh K, Mc Causland FR, Srivastava A, Ikizler TA, Ware LB, Ginde AA, Kellum JA, Palevsky PM, Wolf M, Waikar SS.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):531-541. doi: 10.2215/CJN.10810917. Epub 2018 Mar 8.

PMID:
29519954
6.

Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension.

Reeves PB, Mc Causland FR.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1297-1303. doi: 10.2215/CJN.12141017. Epub 2018 Feb 26. Review.

PMID:
29483138
7.

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.

Mc Causland FR, Claggett B, Pfeffer MA, Burdmann EA, Eckardt KU, Levey AS, McMurray JJV, Remuzzi G, Singh AK, Solomon SD, Toto RD, Parfrey P.

Am J Nephrol. 2017;46(6):488-497. doi: 10.1159/000485326. Epub 2017 Dec 14.

8.

Osmolality and blood pressure stability during hemodialysis.

Singh AT, Mc Causland FR.

Semin Dial. 2017 Nov;30(6):509-517. doi: 10.1111/sdi.12629. Epub 2017 Jul 9. Review.

9.

Dialysate Sodium: Rationale for Evolution over Time.

Flythe JE, Mc Causland FR.

Semin Dial. 2017 Mar;30(2):99-111. doi: 10.1111/sdi.12570. Epub 2017 Jan 8. Review.

10.

Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.

Opotowsky AR, Baraona FR, Mc Causland FR, Loukas B, Landzberg E, Landzberg MJ, Sabbisetti V, Waikar SS.

Heart. 2017 Mar;103(6):434-442. doi: 10.1136/heartjnl-2016-309729. Epub 2016 Sep 26.

11.

C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Mc Causland FR, Claggett B, Burdmann EA, Eckardt KU, Kewalramani R, Levey AS, McMurray JJ, Parfrey P, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA.

Am J Kidney Dis. 2016 Dec;68(6):873-881. doi: 10.1053/j.ajkd.2016.07.022. Epub 2016 Sep 16.

12.

Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study.

Mc Causland FR, Asafu-Adjei J, Betensky RA, Palevsky PM, Waikar SS.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1335-42. doi: 10.2215/CJN.10991015. Epub 2016 Jul 22.

13.

Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline.

Mc Causland FR, Waikar SS.

Am J Kidney Dis. 2015 Sep;66(3):499-506. doi: 10.1053/j.ajkd.2015.03.028. Epub 2015 May 12.

14.

Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery.

Mc Causland FR, Wright J, Waikar SS.

J Hosp Med. 2014 May;9(5):297-302. doi: 10.1002/jhm.2168. Epub 2014 Feb 13.

15.

Optimal dialysate sodium-what is the evidence?

Mc Causland FR, Waikar SS.

Semin Dial. 2014 Mar;27(2):128-34. doi: 10.1111/sdi.12182. Epub 2014 Jan 23. Review.

16.

Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.

Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, Lawler LA, Christie JD, Meyer NJ, Mc Causland FR, Waikar SS, Waxman AB, Chung RT, Bueno R, Rosas IO, Fredenburgh LE, Baron RM, Christiani DC, Hunninghake GM, Choi AM.

PLoS Med. 2013 Dec;10(12):e1001577; discussion e1001577. doi: 10.1371/journal.pmed.1001577. Epub 2013 Dec 31.

17.

Dialysis dose and intradialytic hypotension: results from the HEMO study.

Mc Causland FR, Brunelli SM, Waikar SS.

Am J Nephrol. 2013;38(5):388-96. doi: 10.1159/000355958. Epub 2013 Oct 26.

18.

Race, plasma renin activity, and morning blood pressure surge--results from the Dietary Approaches to Stop Hypertension trial.

Mc Causland FR, McMullan CJ, Sacks FM, Forman JP.

Am J Hypertens. 2014 Apr;27(4):530-6. doi: 10.1093/ajh/hpt031. Epub 2013 Mar 8.

19.

The relevance of dietary sodium in hemodialysis.

Mc Causland FR, Waikar SS, Brunelli SM.

Nephrol Dial Transplant. 2013 Apr;28(4):797-802. doi: 10.1093/ndt/gfs452. Epub 2012 Nov 4. Review.

20.

Association of smoking with cardiovascular and infection-related morbidity and mortality in chronic hemodialysis.

Mc Causland FR, Brunelli SM, Waikar SS.

Clin J Am Soc Nephrol. 2012 Nov;7(11):1827-35. doi: 10.2215/CJN.03880412. Epub 2012 Aug 23.

21.

Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation.

Mc Causland FR, Prior LM, Heher E, Waikar SS.

Am J Nephrol. 2012;36(2):168-74. doi: 10.1159/000341273. Epub 2012 Jul 26.

22.

Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients.

Mc Causland FR, Waikar SS, Brunelli SM.

Kidney Int. 2012 Jul;82(2):204-11. doi: 10.1038/ki.2012.42. Epub 2012 Mar 14.

23.

Dialysate sodium and the milieu intérieur.

Mc Causland FR, Tilley BS, Waikar SS.

Clin J Am Soc Nephrol. 2012 Jan;7(1):5-7. doi: 10.2215/CJN.12101111. Epub 2011 Dec 15. No abstract available.

24.

Dialysate sodium, serum sodium and mortality in maintenance hemodialysis.

Mc Causland FR, Brunelli SM, Waikar SS.

Nephrol Dial Transplant. 2012 Apr;27(4):1613-8. doi: 10.1093/ndt/gfr497. Epub 2011 Sep 2.

25.

Lyme disease-associated glomerulonephritis.

Mc Causland FR, Niedermaier S, Bijol V, Rennke HG, Choi ME, Forman JP.

Nephrol Dial Transplant. 2011 Sep;26(9):3054-6. doi: 10.1093/ndt/gfr335. Epub 2011 Jul 12.

PMID:
21750163

Supplemental Content

Loading ...
Support Center